Brief: Zentalis Pharmaceuticals And Tempus Announce Strategic Collaboration
25/02/2021 12:37
Feb 25 (Reuters) - Tempus Holdings Ltd 6880.HK :
* ZENTALIS PHARMACEUTICALS AND TEMPUS ANNOUNCE STRATEGIC
COLLABORATION TO ADVANCE RESEARCH AND DEVELOPMENT CAPABILITIES
* ZENTALIS PHARMACEUTICALS INC - RETAINS FULL OWNERSHIP OF
ITS
THERAPEUTIC CANDIDATES
Source text for Eikon: ID:nGNXG0CYC
Further company coverage: 6880.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempus Holdings
See all newsBrief: Tempus Says Loan Made Available To Co For Hk$11.25 Million
Brief: Tempus Says Listing Committee Decided To Cancel Co's Listing
Brief: Personalis And Tempus Announce Expanded Collaboration
Brief: Tempus Holdings Says Company And Liquidators Entered Exclusivity Agreement With Investor
Wall Street analysts bullish on genetic testing firm Tempus AI (updated)